To further confirm the results of the WTS and in silico gene expression study, we analyzed and validated the expression of SFN in the triplet set of the NSCLC patient (Figure 4A) and large clinical samples using quantitative PCR (qPCR) analysis (Figure 4B). Here, SFN is linked to non-small cell lung carcinoma.